Turbogen Ltd. director Alex Katz reported a bona fide gift transfer of 80,000 ordinary shares on October 14, 2026. The transaction's reported price per share was $0.00. It was reported as direct ownership, and Katz's direct holdings following the transaction were 1,288,602 ordinary shares.
Turbogen Ltd. (TRBG) amended the reported direct ordinary-share ownership of director Alex Katz, correcting the amount beneficially owned in Table I to 1,368,602 shares. The holding entry is dated August 28, 2026. The amendment says the earlier amount was reported as “1,134,60” and that no other amendment was made to the initial Form 3 filed on August 31, 2026.
TurboGen Ltd. (TRBG) entered into a long-term agreement with an EU-based engineering and manufacturing provider for serial development and production of its proprietary 20kW systems, intended to support sales in defense and civilian markets. The agreement has an initial five-year term with automatic annual renewals designed to support ongoing commercial production.
TurboGen Ltd. (TRBG) amended its Form F-1 prospectus for the resale by selling shareholders of up to 1,764,559 ordinary shares: 829,932 issued in the August 2026 Private Placement and 934,627 issued upon exercise of warrants pursuant to the 2025 Warrant Inducement Agreement. No additional securities are registered by this amendment. TurboGen will not receive proceeds from shareholder resales; net proceeds go to selling shareholders. It separately states it will receive cash proceeds from exercise of the Warrants. Shares issued and outstanding were 25,517,311 as of September 24, 2026.
TurboGen describes itself as a development-stage company with no revenue, cash and cash equivalents of $7.2 million as of June 30, 2026, and approximately $47.7 million in accumulated losses as of that date. Its 2025 financial statements included an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern. TurboGen is negotiating a proposed purchase of Abu Yehiel’s 50% interest in Elbatech, valued at approximately NIS 600 million; the proposed consideration is TurboGen shares, and completion remains subject to a binding agreement.
Turbogen Ltd. (TRBG) reported no revenue for the six months ended June 30, 2026. Net loss narrowed to $4.175 million from $7.629 million a year earlier, while operating loss increased to $5.217 million from $2.261 million. The net-loss improvement primarily reflected a $6.430 million favorable change in warrant fair-value and debt-extinguishment effects, partly offset by higher operating expenses.
Cash and cash equivalents were $7.196 million at June 30, 2026, and operating activities used $2.674 million, versus $1.432 million in the prior-year period. The August private placement raised $5 million gross through 1,131,616 ordinary shares at NIS 13.22 ($4.42) each after its milestone was achieved August 28. Based on expected spending and proceeds from the placement and warrant-inducement agreement, management expected existing cash to fund operations through the end of 2027.
TurboGen’s ordinary shares began Nasdaq Capital Market trading August 31, 2026; warrant exercises resulted in 934,927 ordinary shares issued to Lender A and Lenders F. The company ordered 12 TR3200 systems, with three expected to be installed in Q4 2026 and nine over the following 12 months.
Turbogen Ltd. (TRBG), a developer and manufacturer of multi-fuel microturbines for distributed power generation, announced a strategic business consulting and development agreement with a strategic group that includes Former New York City Mayor Eric Adams. The collaboration is intended to expand Turbogen’s access to strategic customers and partners in the United States and internationally and to support commercialization of its distributed power-generation technology.
Under the agreement, Eric Adams will join Turbogen’s Advisory Board, provide strategic guidance, assist with strategic introductions, and represent the company in U.S. media and other external forums. The strategic group will help identify and develop relationships with potential customers, distributors, and other partners across applications such as commercial and residential buildings, hotels, nursing homes, data centers, and other distributed and off-grid energy uses.
Turbogen Ltd. (TRBG) disclosed the initial insider holdings of Dan Katz, Vice President of Manufacturing. He beneficially owns 37,157 ordinary shares, including time‑based restricted share units that convert into ordinary shares as they vest. These holdings combine directly owned shares with several RSU grants made between 2023 and 2026.
Katz also holds multiple employee stock options to acquire additional ordinary shares, with exercise prices ranging from $1.79 to $6.18 per share and expiration dates between 2031 and 2036. None of these options have been exercised as of late August 2026.
Turbogen Ltd. (TRBG) reported the initial beneficial ownership of director Ari Izhak Natan Even. He holds 30,649 Ordinary shares directly and 6,925,299 Ordinary shares indirectly through Anglo Turbo, Limited Partnership. He also holds a share option to acquire 397,215 Ordinary shares at an exercise price of $0.10 per share, expiring on November 26, 2032. As of August 25, 2026, 198,607 of these options are vested and none have been exercised.
Turbogen Ltd. (TRBG) reported the initial equity holdings of director and Chief Strategic & BD Officer Dov Friedman. As of August 28, 2026, he holds options to acquire 397,215 ordinary shares at an exercise price of $0.10 per share, expiring on November 26, 2032. These options were granted on November 26, 2025; 50% vested on that grant date and the remaining 50% vest on August 31, 2026, and as of August 25, 2026, 198,607 options are fully vested with none exercised.
Friedman also holds 37,944 ordinary shares directly and has 6,925,299 ordinary shares reported as held indirectly through Anglo Turbo, Limited Partnership. Anglo Turbo is controlled by Anglo Energy Micro Turbine Ltd., whose controlling persons are Friedman and Itzhak Natan Even Ari. The option exercise price was originally set at NIS 0.30 per share and converted for reporting purposes using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026.